NTHI — NEONC TECHNOLOGIES HOLDINGS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1979414 ·
Last close
$5.14
Market Cap
$133.71M
52W High
$10.42
52W Low
$3.87
ADV30
90,313
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -7,008,539 | -8,819,932 | 3,330,161 | 138,601 | 16,561,326 |
| Dec 2025 | 0 | — | -13,625,675 | -15,524,104 | 2,823,634 | 58,729 | 20,331,363 |
| Sep 2025 | 0 | — | -6,934,647 | -8,615,920 | 4,082,916 | 1,513,224 | 15,897,186 |
| Jun 2025 | 0 | — | -5,708,034 | -5,680,170 | 2,988,187 | 125,039 | 14,803,681 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,363,949
Investing CF
—
Financing CF
$20,857,784
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.97
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-112,754,655
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-65,317,614
Pretax Income TTM
$-67,822,181
Interest Exp TTM
$2,504,567
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$0
EBITDA
—
Free Cash Flow
$-1,603,043
Enterprise Value
$135,395,776
Total Cash
$138,601
Total Debt
$346,053
Shares Out
26,013,136
Trailing EPS
$-1.77
Book Value
$-0.80
ROE
—
ROA
-354.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 39,990 | -58,169,198 | -62,146,210 | 2,823,634 | 20,331,363 | — | -20,363,948 |
| Dec 2024 | 83,000 | -7,142,522 | -11,898,464 | 3,417,241 | 8,922,202 | — | -4,213,916 |
| Dec 2023 | 70,462 | -8,097,669 | -14,921,065 | 1,265,376 | 15,253,629 | — | -1,880,012 |
| Dec 2022 | 20,000 | -2,837,604 | -3,046,757 | 728,682 | 2,304,093 | — | -881,736 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.64
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GNLX | GENELUX Corp | $134.97M | $3.01 | — |
| CNTB | Connect Biopharma Holdings Ltd | $135.65M | $2.40 | — |
| DERM | Journey Medical Corp | $131.79M | $6.12 | — |
| VTVT | vTv Therapeutics Inc. | $130.61M | $33.16 | — |
| MSLE | Satellos Bioscience Inc. | $141.76M | $6.80 | — |
News headlines (Yahoo Finance, 1h cache)
NeOnc Provides Business Update and Reports Q1 2026 Financial Results
2026-05-18 13:00 · Yahoo
Forget the 242% Biotech Meme. This Brain Cancer Stock Has a $38 Analyst Target and Trades at $6
2026-05-14 15:39 · Yahoo
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
2026-05-05 13:00 · Yahoo
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Gro
2026-04-18 14:00 · Yahoo
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
2026-04-14 13:00 · Yahoo
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
2026-04-01 13:00 · Yahoo
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
2026-03-13 13:00 · Yahoo
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
2026-03-12 12:52 · Yahoo
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m.
2026-03-04 13:00 · Yahoo
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
2026-02-27 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.